Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 23, 2025Cancer Immunology ImmunotherapyOpen Access

A platform for multisite immune profiling of premetastatic pancreatic cancer at single-cell resolution

View Full Paper
Ask AI
Bookmark
Share

Authors

EKElishama KanuAFAshley A. FletcherJBJiayin Bao

Discussion

Loading...

Member takes

Overview

This platform shows distinct immune cell profiles in pancreatic cancer across tumor, liver, and blood, suggesting implications for biomarkers.

Key Points

  • Immune profiling revealed significant differences in T cell populations among various tissues, indicating heterogeneity.
  • Among 106,539 immune cells analyzed, 32 relevant cell populations were identified within different tissue sites.
  • Evaluations of cell-type functionality highlighted critical roles for Tregs and macrophages in the tumor and liver context.
  • The platform's findings may enable tracking immune changes related to metastatic progression in pancreatic cancer.

Cite This Study

Kanu et al. (2025) studied this question.

synapsesocial.com/papers/68af76b97567bf4f94fef937https://doi.org/10.1007/s00262-025-04146-5
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Defining molecular determinants of T cell spatial localization and clonal response throughout PDAC malignant progression 30302025
  2. 2Integrated spatial proteomics of human PDAC uncovers an expanded tumour-immune-stroma spectrum with genomic associations2025
  3. 3Multi-omics analyses inform mechanisms of immunotherapy response in pancreatic cancer2025
  4. 4Integrating multi-modal transcriptomics identifies cellular subtypes with distinct roles in PDAC progression2025 · 6 citations
  5. 5A phase 2 trial of CXCR4 antagonism and PD1 inhibition in metastatic pancreatic adenocarcinoma reveals recruitment of T cells but also immunosuppressive macrophages2025